Potential new cancer fighting drug found by mistake

Researchers in the United States appear to have almost inadvertently stumbled across what could be a new cancer treatment.

Scientist Katherine L. Schaefer and her colleagues were initially rattled to discover that a batch of carefully cultured cells were dead but immediately they realised they were looking at what could be a another weapon to add to the cancer fighting arsenal.

They have found that a group of compounds called peroxisome proliferator-activated receptor-gamma, or PPARgamma inhibitors might have the ability to fight colorectal cancer and cancers of the esophagus, liver and skin.

Tests already carried out in mice suggests the compound helps break down the cell walls of tumours which have learned how to evade existing drugs.

In an even more exciting development the latest studies suggest that PPARgamma inhibitors act through some of the same mechanisms as the blockbuster chemotherapy Taxol, but with important differences.

Lead author Schaefer of the University of Rochester Medical Center, says this is the first observation of a small molecule dramatically reducing levels of the proteins called tubulins, the building blocks of cancer cell skeletons.

Schaefer says because cells that line the colon are similar to those in the liver, esophagus and skin, the discovery represents a potentially new way of treating such cancers.

The original intention of the research was in fact to find drugs to treat the inflammation seen in Crohn's disease and ulcerative colitis which cause pain and diarrhea.

It seems that normal healthy human cells are difficult to grow and study in the lab, because they have a tendency to die, cancer cells live much longer and are harder to kill, which is why scientists often use them.

The research is published in the journal International Cancer Research.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Novel Concepts Medical's plant-based formula achieves 99% reduction in cancer cell viability